Literature DB >> 2907662

Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.

S L Dickinson1, B Gadie, I F Tulloch.   

Abstract

The importance of dopamine (DA) in mediating locomotor, exploratory and stereotyped behaviour in rodents is well established. Evidence also indicates a modulatory role for noradrenaline (NA) although, due to nonspecificity. of previously available agents, a precise role remains undefined. The effects of the specific and selective alpha-adrenoreceptor antagonists idazoxan (alpha 2) and prazosin (alpha 1) on behaviour induced by amphetamine and apomorphine have been investigated in the rat. d-Amphetamine (2 mg/kg) induced hyperactive locomotion and exploration. Pretreatment with prazosin (1 mg/kg) markedly reduced these responses. In contrast, pretreatment with idazoxan (20 mg/kg) only marginally altered d-amphetamine hyperactivity. Apomorphine (0.5 mg/kg) induced biphasic locomotor and exploratory activity. Neither alpha-antagonist affected the initial burst of activity (60 min), although prazosin inhibited whereas idazoxan potentiated the secondary phase (90-180 min). At higher dosage, amphetamine (6 mg/kg) and apomorphine (2 mg/kg) induced stereotyped behaviours. Prazosin pretreatment enhanced stereotyped gnawing and decreased sniffing and locomotion, whereas idazoxan increased locomotion and decreased amphetamine-induced mouth movements. These data indicate that DA-induced locomotor and stereotyped behaviours are differentially influenced (in opposite directions) by both alpha1- and alpha 2-adrenoreceptor antagonists. NA may thus modulate the expression and character of behaviour by influencing DA function in certain brain areas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907662     DOI: 10.1007/BF02180034

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphine.

Authors:  E Mogilnicka; C Braestrup
Journal:  J Pharm Pharmacol       Date:  1976-03       Impact factor: 3.765

2.  A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain.

Authors:  D M Jackson; N E Andén; A Dahlström
Journal:  Psychopharmacologia       Date:  1975-12-31

3.  Modulation of dexamphetamine-induced compulsive gnawing--including the possible involvement of presynaptic alpha-adrenoreceptors.

Authors:  K V Thomas; S L Handley
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

Review 4.  The interrelationship between brain noradrenergic and dopaminergic neuronal systems in regulating animal behavior: possible clinical implications.

Authors:  A Plaźnik; W Kostowski
Journal:  Psychopharmacol Bull       Date:  1983

5.  The pharmacological and anatomical substrates of the amphetamine response in the rat.

Authors:  I Creese; S D Iversen
Journal:  Brain Res       Date:  1975-01-17       Impact factor: 3.252

6.  Characterisation of the mechanisms for hyperactivity induction from the nucleus accumbens by phenylethylamine derivatives.

Authors:  B Costall; R J Naylor; R M Pinder
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

7.  Modulation of the behavioral effects of amphetamine in rats by clonidine.

Authors:  K Mueller; W L Nyhan
Journal:  Eur J Pharmacol       Date:  1982-09-24       Impact factor: 4.432

8.  Alpha 2-adrenoceptors mediate clonidine-induced sedation in the rat.

Authors:  G M Drew; A J Gower; A S Marriott
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

9.  Comparison of the effects of recently developed alpha 2-adrenergic antagonists with yohimbine and rauwolscine on monoamine synthesis in rat brain.

Authors:  D J Pettibone; A B Pfleuger; J A Totaro
Journal:  Biochem Pharmacol       Date:  1985-04-01       Impact factor: 5.858

10.  Behavioural responses to stereotactically controlled injections of monoamine neurotransmitters into the accumbens and caudate-putamen nuclei.

Authors:  R O Makanjuola; R C Dow; G W Ashcroft
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  30 in total

1.  Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.

Authors:  Masato Hara; Ryuichi Fukui; Eriko Hieda; Mahomi Kuroiwa; Helen S Bateup; Tatsuhiko Kano; Paul Greengard; Akinori Nishi
Journal:  J Neurochem       Date:  2010-03-04       Impact factor: 5.372

2.  Effects of noradrenergic alpha-2 receptor antagonism or noradrenergic lesions in the ventral bed nucleus of the stria terminalis and medial preoptic area on maternal care in female rats.

Authors:  Carl D Smith; M Allie Holschbach; Joshua Olsewicz; Joseph S Lonstein
Journal:  Psychopharmacology (Berl)       Date:  2012-05-29       Impact factor: 4.530

3.  Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.

Authors:  J Srinivasan; W J Schmidt
Journal:  J Neural Transm (Vienna)       Date:  2004-12-22       Impact factor: 3.575

4.  Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice.

Authors:  Jian-Hui Liang; Keng Wang; Hong-Lei Sun; Rong Han
Journal:  Psychopharmacology (Berl)       Date:  2006-01-24       Impact factor: 4.530

5.  Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants.

Authors:  Jason M Uslaner; Sean M Smith; Sarah L Huszar; Rashida Pachmerhiwala; Richard M Hinchliffe; Joshua D Vardigan; Pete H Hutson
Journal:  Psychopharmacology (Berl)       Date:  2009-08-26       Impact factor: 4.530

6.  6-Hydroxydopamine lesion of locus coeruleus and the antiparkinsonian potential of NMDA-receptor antagonists in rats.

Authors:  N Rückert; M Bubser; W J Schmidt
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan.

Authors:  D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  The alpha2-adrenoceptor antagonist atipamezole reduces the development and expression of d-amphetamine-induced behavioural sensitization.

Authors:  Juuso Juhila; Antti Haapalinna; Jouni Sirviö; Jukka Sallinen; Aapo Honkanen; Esa R Korpi; Mika Scheinin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-14       Impact factor: 3.000

9.  The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?

Authors:  J Srinivasan; Werner J Schmidt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-29       Impact factor: 3.000

10.  Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats.

Authors:  Matthew I Palmatier; Melissa E Levin; Kara L Mays; Eric C Donny; Anthony R Caggiula; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2009-09-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.